ArNiko BioMed
ArNiko BioMed is a biopharmaceutical solutions company founded to accelerate customers’ success. It provides medical writing and editing services for a wide variety of regulatory clinical documents and clinical publications.
Our experts have extensive experience supporting both single-document and large-scale submissions across a diverse range of indications and broad knowledge of ICH and GCP guidelines and best industry practices and solid clinical and scientific background.
ArNiko BioMed’s team supports preparation of various medical communication and regulatory documents and services, including:
- Phase I-IV Clinical Study Reports
- Phase 1-IV Clinical Study Protocols
- Protocol amendments
- Patient Safety Narratives
- Clinical Summaries of Safety
- Clinical Summaries of Efficacy
- Investigator’s brochures
- Briefing book
- Regulatory responses
- Clinical and scientific manuscripts
- Lay summaries
- Medical editing
News
ArNiko BioMed now provides Medical Writing Services to EMEA, USA, Japan and Australia.